ID23799A - Penggunaan antagonis reseptor 5ht2 spesifik untuk pembuatan obat obatan yang berguna dalam pengobatan sindrom apnea saat tidur - Google Patents

Penggunaan antagonis reseptor 5ht2 spesifik untuk pembuatan obat obatan yang berguna dalam pengobatan sindrom apnea saat tidur

Info

Publication number
ID23799A
ID23799A IDW991677A ID991677A ID23799A ID 23799 A ID23799 A ID 23799A ID W991677 A IDW991677 A ID W991677A ID 991677 A ID991677 A ID 991677A ID 23799 A ID23799 A ID 23799A
Authority
ID
Indonesia
Prior art keywords
treatment
sleep
apnea syndrome
pct
medicine
Prior art date
Application number
IDW991677A
Other languages
English (en)
Inventor
Francoise Cattelin
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of ID23799A publication Critical patent/ID23799A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW991677A 1997-06-26 1998-06-02 Penggunaan antagonis reseptor 5ht2 spesifik untuk pembuatan obat obatan yang berguna dalam pengobatan sindrom apnea saat tidur ID23799A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707998A FR2765107B1 (fr) 1997-06-26 1997-06-26 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil

Publications (1)

Publication Number Publication Date
ID23799A true ID23799A (id) 2000-05-11

Family

ID=9508467

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991677A ID23799A (id) 1997-06-26 1998-06-02 Penggunaan antagonis reseptor 5ht2 spesifik untuk pembuatan obat obatan yang berguna dalam pengobatan sindrom apnea saat tidur

Country Status (29)

Country Link
US (1) US6143792A (id)
EP (1) EP1014960B1 (id)
JP (1) JP3503953B2 (id)
KR (1) KR20010014186A (id)
CN (1) CN1154485C (id)
AT (1) ATE232094T1 (id)
AU (1) AU728227B2 (id)
BG (1) BG104038A (id)
BR (1) BR9810337A (id)
CA (1) CA2295119C (id)
CZ (1) CZ291935B6 (id)
DE (1) DE69811248T2 (id)
EE (1) EE9900595A (id)
ES (1) ES2191942T3 (id)
FR (1) FR2765107B1 (id)
HK (1) HK1028351A1 (id)
HU (1) HU229058B1 (id)
ID (1) ID23799A (id)
IL (1) IL133632A (id)
IS (1) IS2356B (id)
NO (1) NO325520B1 (id)
NZ (1) NZ502495A (id)
PL (1) PL190723B1 (id)
RU (1) RU2218917C2 (id)
SK (1) SK283845B6 (id)
TR (1) TR199903197T2 (id)
TW (1) TW580386B (id)
UA (1) UA59397C2 (id)
WO (1) WO1999000119A1 (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331536B1 (en) 1998-02-27 2001-12-18 The Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
FR2787328A1 (fr) * 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
US6548082B1 (en) * 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
DE60311822T2 (de) * 2002-07-19 2007-12-06 Biovitrum Ab Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
KR20070087678A (ko) 2004-12-20 2007-08-28 컬리지움 파마슈티칼, 인코포레이티드 수면 장애용 약제 조성물
EP2186511A1 (en) * 2008-11-13 2010-05-19 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
JP2012508792A (ja) * 2008-11-13 2012-04-12 サノフイ エプリバンセリンを使用して睡眠障害を治療する方法
EP2266554A1 (en) * 2009-05-26 2010-12-29 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2255726A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2039102A1 (en) * 1990-03-29 1991-09-30 David W. Robertson Compounds affecting serotonin receptors
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
DE69811248D1 (de) 2003-03-13
CA2295119A1 (en) 1999-01-07
AU8024398A (en) 1999-01-19
RU2218917C2 (ru) 2003-12-20
ATE232094T1 (de) 2003-02-15
DE69811248T2 (de) 2003-12-04
PL190723B1 (pl) 2005-12-30
CN1154485C (zh) 2004-06-23
UA59397C2 (uk) 2003-09-15
TW580386B (en) 2004-03-21
AU728227B2 (en) 2001-01-04
SK283845B6 (sk) 2004-03-02
HU229058B1 (en) 2013-07-29
PL337871A1 (en) 2000-09-11
BR9810337A (pt) 2000-09-05
JP3503953B2 (ja) 2004-03-08
JP2001520678A (ja) 2001-10-30
NZ502495A (en) 2000-10-27
SK184599A3 (en) 2000-06-12
IL133632A0 (en) 2001-04-30
EE9900595A (et) 2000-08-15
NO996442D0 (no) 1999-12-23
IL133632A (en) 2003-10-31
US6143792A (en) 2000-11-07
EP1014960B1 (fr) 2003-02-05
HK1028351A1 (en) 2001-02-16
KR20010014186A (ko) 2001-02-26
NO996442L (no) 2000-02-28
FR2765107B1 (fr) 2000-03-24
IS5316A (is) 1999-12-21
CZ291935B6 (cs) 2003-06-18
NO325520B1 (no) 2008-06-02
HUP0002170A2 (hu) 2001-11-28
EP1014960A1 (fr) 2000-07-05
BG104038A (en) 2001-04-30
IS2356B (is) 2008-04-15
FR2765107A1 (fr) 1998-12-31
TR199903197T2 (xx) 2000-05-22
WO1999000119A1 (fr) 1999-01-07
HUP0002170A3 (en) 2001-12-28
CZ469599A3 (cs) 2000-04-12
CA2295119C (en) 2007-02-13
CN1265586A (zh) 2000-09-06
ES2191942T3 (es) 2003-09-16

Similar Documents

Publication Publication Date Title
ID23799A (id) Penggunaan antagonis reseptor 5ht2 spesifik untuk pembuatan obat obatan yang berguna dalam pengobatan sindrom apnea saat tidur
ATE175114T1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin- vermittelten krankheiten
DE69400435D1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
AP2000001785A0 (en) Medicaments
MX9307884A (es) Aplicacion de la carbamazepina o la oxcarbamazepina para la preparacion de medicamentos para el tratamiento de lesiones neurologicas ligadas a traumatismos.
NZ337827A (en) Use of GluR5 receptor antagonists in the manufacture of medicaments for treating pain
SE9702651D0 (sv) Novel compounds
EE04177B1 (et) 1-(2-naft-2-üületüül)-4-(3-trifluorometüülfenüül)-1,2,3,6-tetrahüdropüridiini kasutamine ravimite valmistamiseks amüotroofilise lateraalskleroosi raviks
MXPA01008993A (es) Tratamiento de combinacion para depresion y ansiedad.
IL206566A0 (en) Use of an antagonist to the igs4 neuromedin receptor polypeptide for the preparation of a medicament for the treatment of a disease related to the expression or acitivity of the igs4 neuromedin receptor polypeptide
SG160197A1 (en) Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
ATE297732T1 (de) Kombinationstherapie zur behandlung von herzinsuffizienz
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
EE9700366A (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
AU5981200A (en) Transdermal therapeutic system for administering a calcium antagonist
IL143143A0 (en) USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS
IL108283A0 (en) Use of riluzole for promoting restoration following radiation